May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Molecular Diagnosis and Therapeutic Modalities of Chronic Cytomegalovirus Uveitis Without Retinitis
Author Affiliations & Notes
  • I. De Schryver
    Ophthalmology, Univ Hosp Ghent, Ghent, Belgium
    Ophthalmology, University of Paris VI, Pitié–Salpetrière Hospital, Paris, France
  • F. Rozenberg
    Laboratory of Virology, Hopital Saint Vincent de Paul, Paris, France
  • N. Cassoux
    Ophthalmology, University of Paris VI, Pitié–Salpetrière Hospital, Paris, France
  • S. Michelson
    Laboratory of viral immunology, Pasteur Institute, Paris, France
  • P. Kestelyn
    Ophthalmology, Univ Hosp Ghent, Ghent, Belgium
  • P. LeHoang
    Ophthalmology, University of Paris VI, Pitié–Salpetrière Hospital, Paris, France
  • J. Davis
    Bascom Palmer Eye Institute, University of Miami Shool of Medicine, Miami, FL
  • B. Bodaghi
    Ophthalmology, University of Paris VI, Pitié–Salpetrière Hospital, Paris, France
  • Footnotes
    Commercial Relationships  I. De Schryver, None; F. Rozenberg, None; N. Cassoux, None; S. Michelson, None; P. Kestelyn, None; P. LeHoang, None; J. Davis, None; B. Bodaghi, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1034. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      I. De Schryver, F. Rozenberg, N. Cassoux, S. Michelson, P. Kestelyn, P. LeHoang, J. Davis, B. Bodaghi; Molecular Diagnosis and Therapeutic Modalities of Chronic Cytomegalovirus Uveitis Without Retinitis . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1034.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: CMV uveitis may occur in the absence of retinal necrosis in immunocompetent patients. The aim of our study was to define the clinical features and the diagnostic and therapeutic management of this condition. Patients and methods : Patients referred between 2001 and 2004 for management of unilateral, chronic, relapsing uveitis associated with secondary glaucoma underwent extensive work–up, including laboratory tests for different herpesvirus infections. Specific antiviral treatment was initiated in all cases and the level of ocular inflammation was evaluated during the follow–up. Results:Seven patients, 5 men and 2 women were included. Mean age was 45.3 years (range 17–80 years). Anterior unilateral chronic uveitis without iris atrophy was observed in all cases. Slit lamp biomicroscopy disclosed presumable viral uveitis in 3 cases and Posner–Schlossman like syndrome in 4 cases. Mean intraocular pressure was 30.5 mmHg (range 22–43 mmHg). All patients responded initially to specific anti–CMV therapy. Ocular inflammation and glaucoma were controlled in all cases, but relapses occurred in 3 cases, requiring prolonged maintenance therapy with valganciclovir.Conclusions: Viral–like uveitis may be resistant to acyclovir. CMV infection should be considered in order to propose specific antiviral therapy. Maintenance regimens of valganciclovir are mandatory to prevent further relapses.

Keywords: cytomegalovirus • uveitis-clinical/animal model • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×